Thyroid Cancer | Topics

 
Improved Overall Survival Observed With Lenvatinib for Patients With Thyroid Cancer and Lung Metastases
May 11, 2021

Investigators observed a survival benefit for patients receiving lenvatinib who had radioiodine-refractory differentiated thyroid cancer with lung metastases of 1 cm or greater.

Study Identifies Effectiveness of RNA, DNA-RNA Tests for Diagnosis of Indeterminate Thyroid Nodules
December 29, 2020

“Although previous trials demonstrated that the prior version of the DNA-RNA test was more specific than the prior version of the RNA test, the current molecular test techniques have no statistically significant difference in performance,” wrote Masha J. Livhits, MD, and colleagues.

FDA Approves Pralsetinib to Treat RET-Altered Thyroid Cancers
December 01, 2020

The FDA granted accelerated approval to pralsetinib to treat with advanced or metastatic RET-mutant medullary thyroid cancer or RET fusion-positive thyroid cancer.